Carl Zeiss Meditec Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Carl Zeiss Meditec kazanç ve gelirin sırasıyla yıllık 16.3% ve 7.9% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 16.7% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11.9% olacağı tahmin edilmektedir.

Anahtar bilgiler

16.3%

Kazanç büyüme oranı

16.7%

EPS büyüme oranı

Medical Equipment kazanç büyümesi	14.2%
Gelir büyüme oranı	7.9%
Gelecekteki özkaynak getirisi	11.9%
Analist kapsamı	Good
Son güncelleme	15 Nov 2024

Gelecekteki son büyüme güncellemeleri

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11

Recent updates

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Sep 19

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Aug 23

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Nov 04

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Oct 18

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Sep 12

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Aug 25

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

May 30

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Feb 27

Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Feb 08

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Dec 12

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Nov 06

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Sep 06

Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Aug 08

Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

May 21

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 18

Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Apr 28

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

Mar 09

How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

Feb 16

Kazanç ve Gelir Büyüme Tahminleri

XTRA:AFX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (EUR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2027	2,686	316	238	N/A	6
9/30/2026	2,455	256	248	N/A	13
9/30/2025	2,275	205	209	N/A	15
9/30/2024	2,073	162	176	N/A	15
6/30/2024	2,066	203	N/A	N/A	N/A
3/31/2024	2,062	261	122	263	N/A
12/31/2023	2,094	277	N/A	N/A	N/A
9/30/2023	2,089	290	137	251	N/A
6/30/2023	2,080	308	N/A	N/A	N/A
3/31/2023	2,022	278	63	162	N/A
12/31/2022	1,963	307	N/A	N/A	N/A
9/30/2022	1,903	294	106	188	N/A
6/30/2022	1,781	245	N/A	N/A	N/A
3/31/2022	1,735	264	207	285	N/A
12/31/2021	1,688	228	N/A	N/A	N/A
9/30/2021	1,647	236	297	363	N/A
6/30/2021	1,566	235	N/A	N/A	N/A
3/31/2021	1,388	159	240	290	N/A
12/31/2020	1,335	130	N/A	N/A	N/A
9/30/2020	1,335	122	134	179	N/A
6/30/2020	1,400	120	N/A	N/A	N/A
3/31/2020	1,507	166	132	171	N/A
12/31/2019	1,505	170	N/A	N/A	N/A
9/30/2019	1,459	160	173	220	N/A
6/30/2019	1,382	153	N/A	N/A	N/A
3/31/2019	1,334	129	195	242	N/A
12/31/2018	1,310	127	N/A	N/A	N/A
9/30/2018	1,281	126	152	187	N/A
6/30/2018	1,251	124	N/A	N/A	N/A
3/31/2018	1,216	129	N/A	56	N/A
12/31/2017	1,205	132	N/A	N/A	N/A
9/30/2017	1,190	134	N/A	38	N/A
6/30/2017	1,154	123	N/A	N/A	N/A
3/31/2017	1,135	112	N/A	85	N/A
12/31/2016	1,106	113	N/A	N/A	N/A
9/30/2016	1,088	98	N/A	112	N/A
6/30/2016	1,090	78	N/A	132	N/A
3/31/2016	1,083	80	N/A	96	N/A
12/31/2015	1,062	61	N/A	73	N/A
9/30/2015	1,040	62	N/A	57	N/A
6/30/2015	984	70	N/A	34	N/A
3/31/2015	946	66	N/A	44	N/A
12/31/2014	938	73	N/A	60	N/A
9/30/2014	909	75	N/A	63	N/A
6/30/2014	931	83	N/A	74	N/A
3/31/2014	924	89	N/A	69	N/A
12/31/2013	900	89	N/A	52	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AFX 'nin tahmini kazanç büyümesi (yıllık 16.3% ) tasarruf oranının ( 1% ) üzerindedir.

Kazançlar ve Piyasa: AFX şirketinin kazançlarının (yıllık 16.3% ) German pazarından (yıllık 20.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: AFX şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: AFX şirketinin gelirinin (yıllık 7.9% ) German pazarından (yıllık 5.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AFX şirketinin gelirinin (yıllık 7.9% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AFX 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11.9 %).

Carl Zeiss Meditec Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 10%

Price target decreased by 12% to €91.60

Consensus EPS estimates fall by 16%

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target decreased by 9.6% to €99.15

Price target decreased by 10% to €114

Recent updates

Investor sentiment improves as stock rises 26%

Now 25% overvalued after recent price rise

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Consensus EPS estimates fall by 10%

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Price target decreased by 12% to €91.60

Consensus EPS estimates fall by 16%

Carl Zeiss Meditec AG to Report Nine Months, 2024 Results on Aug 06, 2024

Investor sentiment deteriorates as stock falls 22%

Now 30% undervalued after recent price drop

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

ZEISS Announces OCT Technology Enhancements to Better Support Growing Era of Data-Driven Patient Care

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Upcoming dividend of €1.10 per share

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

First quarter 2024 earnings: EPS exceeds analyst expectations

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Carl Zeiss Meditec AG to Report First Half, 2024 Results on May 08, 2024

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG, Annual General Meeting, Mar 21, 2024

Carl Zeiss Meditec AG Announces U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS

Full year 2023 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 15%

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Price target decreased by 9.6% to €99.15

Now 20% undervalued after recent price drop

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Now 21% undervalued after recent price drop

ZEISS Reimagined the Iconic Pentero Platform for Digital Age

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Price target decreased by 10% to €114

Third quarter 2023 earnings: EPS exceeds analyst expectations

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Upcoming dividend of €1.10 per share at 0.8% yield

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Full year 2022 earnings: EPS and revenues exceed analyst expectations

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Carl Zeiss Meditec AG to Report Q1, 2023 Results on Feb 10, 2023

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

Carl Zeiss Meditec AG Reaffirms Earning Guidance for 2022

Carl Zeiss Meditec AG (XTRA:AFX) acquired Kogent Surgical, LLC and Katalyst Surgical, LLC.

Upcoming dividend of €0.90 per share

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS misses analyst expectations

Carl Zeiss Meditec AG Reaffirms Earnings Guidance for the Year 2021/22